Company's New DuraMax VascPak™ Kit Targets Vascular Access Centers
ALBANY, N.Y.--(BUSINESS WIRE)--
AngioDynamics (NASDAQ:ANGO) announced today the U.S. launch and initial
shipments of the next generation DuraMax® stepped-tip chronic
dialysis catheter and the DuraMaxVP (VascPak™) kit.
The next generation DuraMax(R) stepped-tip chronic dialysis catheter from AngioDynamics(R). (Photo: Business Wire)
The DuraMax catheter provides optimal ease of insertion and high
performance blood flow rates. It features a proprietary guidewire lumen
designed to significantly improve catheter placement by securely fixing
the guidewire in the center of the leading edge of the catheter at the
insertion site.
"Approximately 30-50% of chronic dialysis catheters are placed over a
guidewire, and DuraMax offers a significant improvement in ease of
catheter placement," said Shawn McCarthy, Senior Vice President and
General Manager for AngioDynamics. "The DuraMax chronic dialysis
catheter employs AngioDynamics' highly innovative and proprietary Curved
Tip™ Catheter Technology, which is designed to improve patient outcomes
by providing higher blood flow over a longer timeframe at lower
recirculation rates, even if the catheter becomes positioned against a
vessel wall."
The new DuraMaxVP (VascPak) product offers a streamlined component kit
designed to appeal to vascular access centers and open this new segment
for AngioDynamics. Up to 45% of all chronic dialysis catheter placements
— more than 180,000 placements in 2011 — are performed in these
outpatient centers.
About AngioDynamics
AngioDynamics, Inc. is a leading provider of innovative, minimally
invasive medical devices used by professional healthcare providers for
vascular access, surgery, treatment of peripheral vascular disease and
oncology procedures. AngioDynamics' diverse product lines include
market-leading ablation systems, vascular access products, angiographic
products and accessories, angioplasty products, drainage products,
thrombolytic products, embolization products and venous products. More
information is available at www.angiodynamics.com.
Photos/Multimedia Gallery Available: http://www.businesswire.com/cgi-bin/mmg.cgi?eid=6669337&lang=en
AngioDynamics, Inc.
D. Joseph Gersuk, CFO,
800-772-6446 ext. 1608
jgersuk@AngioDynamics.com
or
EVC
Group, Inc.
Doug Sherk, 415-896-6820 (Investor Relations)
dsherk@evcgroup.com
Greg
Gin, 415-896-6820 (Investor Relations)
ggin@evcgroup.com
Chris
Gale, 646-201-5431 (Media)
cgale@evcgroup.com
Source: AngioDynamics, Inc.
News Provided by Acquire Media
